" /> Dose-dense AC Followed by Dose-Dense Paclitaxel/Trastuzumab Regimen - CISMeF





Preferred Label : Dose-dense AC Followed by Dose-Dense Paclitaxel/Trastuzumab Regimen;

NCIt synonyms : Dose-dense AC Followed by Dose-Dense Paclitaxel Plus Trastuzumab; Dose-dense AC Followed by Dose-Dense Paclitaxel Plus Trastuzumab Regimen; Dose-dense Adriamycin/Cytoxan Followed by Dose-dense Taxol Plus Herceptin; Dose-dense Doxorubicin/Cyclophosphamide Followed by Dose-dense Paclitaxel Plus Trastuzumab; DD Doxorubicin/Cyclophosphamide Followed by DD Paclitaxel Plus Trastuzumab;

NCIt related terms : ddAC-ddTH (Paclitaxel) (trastuzumab-qyyp); ddAC-ddTH (Paclitaxel); ddAC-ddTH (Paclitaxel) (trastuzumab-zerc); ddAC-ddTH (Paclitaxel) (trastuzumab-anns); ddAC-ddTH (Paclitaxel) (trastuzumab-dkst); ddAC-ddTH (Paclitaxel) (trastuzumab-pkrb); ddAC-ddTH (Paclitaxel) (trastuzumab-herw); ddAC-ddTH (Paclitaxel) (trastuzumab-dttb);

NCIt definition : A regimen consisting of doxorubicin and cyclophosphamide, followed by a dose-dense regimen of paclitaxel, and trastuzumab that may be used in the treatment of breast cancer.;

NCI Metathesaurus CUI : CL1905243;

Codes from synonyms : 128937; 129325; 129228; 129422; 63563; 128840; 129131; 129034;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
30/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.